Differential effects of Escherichia coli nissle and lactobacillus rhamnosus strain GG on human rotavirus binding, infection, and B cell immunity

Journal of Immunology

Volumn 196, Issue 4, 2016, Pages 1780-1789

  Kandasamy, Sukumar ^a   Vlasova, Anastasia N ^a   Fischer, David ^a   Kumar, Anand ^a   Chattha, Kuldeep S ^a   Rauf, Abdul ^a   Shao, Lulu ^a   Langel, Stephanie N ^a   Rajashekara, Gireesh ^a   Saif, Linda J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD79B ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 6; PROBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BINDING AFFINITY; CELLULAR IMMUNITY; COLONY FORMING UNIT; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOMODULATION; LACTOBACILLUS RHAMNOSUS; MONONUCLEAR CELL; NONHUMAN; PIGLET; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION; STRAIN DIFFERENCE; VIRUS ATTACHMENT; VIRUS PARTICLE; VIRUS SHEDDING; VIRUS TITRATION; VIRUS VIRULENCE; ANIMAL; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PIG;

ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; ROTAVIRUS; ROTAVIRUS INFECTIONS; SWINE;

EID: 84958581217     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501705     Document Type: Article

References (69)

1. Tate, J. E., A. H. Burton, C. Boschi-Pinto, A. D. Steele, J. Duque, and U. D. Parashar, WHO-coordinated Global Rotavirus Surveillance Network. 2012. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect. Dis. 12: 136-141.
2. Viboud, C., B. A. Lopman, V. E. Pitzer, R. Sarkar, B. Gladstone, M. Patel, J. Glasser, M. Gambhir, C. Atchison, and B. T. Grenfell. 2012. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PloS One 7: Article ID e41720, 41727 pages.
3. Ferreira, R. B., L. C. M. Antunes, and B. B. Finlay. 2010. Should the human microbiome be considered when developing vaccines? PLoS Pathog. 6: e1001190.
4. Qadri, F., T. R. Bhuiyan, D. A. Sack, and A. M. Svennerholm. 2013. Immune responses and protection in children in developing countries induced by oral vaccines. Vaccine 31: 452-460.
5. Valdez, Y., E. M. Brown, and B. B. Finlay. 2014. Influence of the microbiota on vaccine effectiveness. Trends Immunol. 35: 526-537.
6. Wilks, J., and T. Golovkina. 2012. Influence of microbiota on viral infections. PLoS Pathog. 8: e1002681.
7. Robinson, C. M., and J. K. Pfeiffer. 2014. Viruses and the microbiota. Ann. Rev. Virol. 1: 55-69.
8. Uchiyama, R., B. Chassaing, B. Zhang, and A. T. Gewirtz. 2014. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J. Infect. Dis. 210: 171-182.
9. Huda, M. N., Z. Lewis, K. M. Kalanetra, M. Rashid, S. M. Ahmad, R. Raqib, F. Qadri, M. A. Underwood, D. A. Mills, and C. B. Stephensen. 2014. Stool microbiota and vaccine responses of infants. Pediatrics 134: e362-e372.
10. Kuss, S. K., G. T. Best, C. A. Etheredge, A. J. Pruijssers, J. M. Frierson, L. V. Hooper, T. S. Dermody, and J. K. Pfeiffer. 2011. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334: 249-252.
11. Kane, M., L. K. Case, K. Kopaskie, A. Kozlova, C. MacDearmid, A. V. Chervonsky, and T. V. Golovkina. 2011. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334: 245-249.
12. Szajewska, H., and J. Z. Mrukowicz. 2001. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: A systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr. 33(Suppl. 2): S17-S25.
13. Sanders, M. E., F. Guarner, R. Guerrant, P. R. Holt, E. M. Quigley, R. B. Sartor, P. M. Sherman, and E. A. Mayer. 2013. An update on the use and investigation of probiotics in health and disease. Gut 62: 787-796.
14. Majamaa, H., E. Isolauri, M. Saxelin, and T. Vesikari. 1995. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr. 20: 333-338.
15. Kaila, M., E. Isolauri, E. Soppi, E. Virtanen, S. Laine, and H. Arvilommi. 1992. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res. 32: 141-144.
16. Zhang, W., M. S. Azevedo, K. Wen, A. Gonzalez, L. J. Saif, G. Li, A. E. Yousef, and L. Yuan. 2008. Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs. Vaccine 26: 3655-3661.
17. Chattha, K. S., A. N. Vlasova, S. Kandasamy, G. Rajashekara, and L. J. Saif. 2013. Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model. J. Immunol. 191: 2446-2456.
18. Kandasamy, S., K. S. Chattha, A. N. Vlasova, G. Rajashekara, and L. J. Saif. 2014. Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model. Gut Microbes 5: 639-651.
19. Vlasova, A. N., K. S. Chattha, S. Kandasamy, Z. Liu, M. Esseili, L. Shao, G. Rajashekara, and L. J. Saif. 2013. Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs. PLoS One 8: e76962.
20. Guandalini, S., L. Pensabene, M. A. Zikri, J. A. Dias, L. G. Casali, H. Hoekstra, S. Kolacek, K. Massar, D. Micetic-Turk, A. Papadopoulou, et al. 2000. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: A multicenter European trial. J. Pediatr. Gastroenterol. Nutr. 30: 54-60.
21. Nowrouzian, F., B. Hesselmar, R. Saalman, I. L. Strannegard, N. Aberg, A. E. Wold, and I. Adlerberth. 2003. Escherichia coli in infants' intestinal microflora: colonization rate, strain turnover, and virulence gene carriage. Pediatr. Res. 54: 8-14.
22. Kruis, W., P. Fric, J. Pokrotnieks, M. Lukás, B. Fixa, M. Kascák, M. A. Kamm, J. Weismueller, C. Beglinger, M. Stolte, et al. 2004. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617-1623.
23. Hering, N. A., J. F. Richter, A. Fromm, A. Wieser, S. Hartmann, D. Gunzel, R. Bucker, M. Fromm, J. D. Schulzke, and H. Troeger. 2014. TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCz and ERK1/2 signaling in HT-29/B6 cells. Mucosal Immunol. 7: 369-378.
24. Rembacken, B. J., A. M. Snelling, P. M. Hawkey, D. M. Chalmers, and A. T. Axon. 1999. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet 354: 635-639.
25. Altenhoefer, A., S. Oswald, U. Sonnenborn, C. Enders, J. Schulze, J. Hacker, and T. A. Oelschlaeger. 2004. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol. Med. Microbiol. 40: 223-229.
26. Schlee, M., J. Wehkamp, A. Altenhoefer, T. A. Oelschlaeger, E. F. Stange, and K. Fellermann. 2007. Induction of human b-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75: 2399-2407.
27. Sturm, A., K. Rilling, D. C. Baumgart, K. Gargas, T. Abou-Ghazalé, B. Raupach, J. Eckert, R. R. Schumann, C. Enders, U. Sonnenborn, et al. 2005. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via Tolllike receptor 2 signaling. Infect. Immun. 73: 1452-1465.
28. Saif, L., L. Ward, L. Yuan, B. Rosen, and T. To. 1996. The Gnotobiotic Piglet as a Model for Studies of Disease Pathogenesis and Immunity to Human Rotaviruses. Springer, Vienna, Austria.
29. Butler, J. E., K. M. Lager, I. Splichal, D. Francis, I. Kacskovics, M. Sinkora, N. Wertz, J. Sun, Y. Zhao, W. R. Brown, et al. 2009. The piglet as a model for B cell and immune system development. Vet. Immunol. Immunopathol. 128: 147-170.
30. Butler, J. E., J. Sun, P. Weber, S. P. Ford, Z. Rehakova, J. Sinkora, and K. Lager. 2001. Antibody repertoire development in fetal and neonatal piglets. IV. Switch recombination, primarily in fetal thymus, occurs independent of environmental antigen and is only weakly associated with repertoire diversification. J. Immunol. 167: 3239-3249.
31. Sinkora, M., J. Sinkorova, and J. E. Butler. 2002. B cell development and VDJ rearrangement in the fetal pig. Vet. Immunol. Immunopathol. 87: 341-346.
32. Meyer, R. C., E. H. Bohl, and E. M. Kohler. 1964. Procurement and maintenance of germ-free seine for microbiological investigations. Appl. Microbiol. 12: 295-300.
33. Kumar, A., A. N. Vlasova, Z. Liu, K. S. Chattha, S. Kandasamy, M. Esseili, X. Zhang, G. Rajashekara, and L. J. Saif. 2014. In vivo gut transcriptome responses to Lactobacillus rhamnosus GG and Lactobacillus acidophilus in neonatal gnotobiotic piglets. Gut Microbes 5: 152-164.
34. Ward, L. A., B. I. Rosen, L. Yuan, and L. J. Saif. 1996. Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs. J. Gen. Virol. 77: 1431-1441.
35. Yuan, L., S. Y. Kang, L. A. Ward, T. L. To, and L. J. Saif. 1998. Antibodysecreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus. J. Virol. 72: 330-338.
36. Yuan, L., L. A. Ward, B. I. Rosen, T. L. To, and L. J. Saif. 1996. Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 70: 3075-3083.
37. Parrenõ, V., D. C. Hodgins, L. de Arriba, S. Y. Kang, L. Yuan, L. A. Ward, T. L. Tô , and L. J. Saif. 1999. Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies. J. Gen. Virol. 80: 1417-1428.
38. Sinkora, M., K. Stepanova, J. E. Butler, D. Francis, K. Santiago-Mateo, H. Potockova, K. Karova, and J. Sinkorova. 2011. Ileal Peyer's patches are not necessary for systemic B cell development and maintenance and do not contribute significantly to the overall B cell pool in swine. J. Immunol. 187: 5150-5161.
39. Zhang, W., M. S. Azevedo, A. M. Gonzalez, L. J. Saif, T. Van Nguyen, K. Wen, A. E. Yousef, and L. Yuan. 2008. Influence of probiotic Lactobacilli colonization on neonatal B cell responses in a gnotobiotic pig model of human rotavirus infection and disease. Vet. Immunol. Immunopathol. 122: 175-181.
40. Cukrowska, B., R. LodInová-ZádnIková, C. Enders, U. Sonnenborn, J. Schulze, and H. Tlaskalová-Hogenová. 2002. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand. J. Immunol. 55: 204-209.
41. Graham, K. L., P. Halasz, Y. Tan, M. J. Hewish, Y. Takada, E. R. Mackow, M. K. Robinson, and B. S. Coulson. 2003. Integrin-using rotaviruses bind a2b1 integrin a2 I domain via VP4 DGE sequence and recognize aXb2 and aVb3 by using VP7 during cell entry. J. Virol. 77: 9969-9978.
42. Hewish, M. J., Y. Takada, and B. S. Coulson. 2000. Integrins a2b1 and a4b1 can mediate SA11 rotavirus attachment and entry into cells. J. Virol. 74: 228-236.
43. Letourneau, J., C. Levesque, F. Berthiaume, M. Jacques, and M. Mourez. 2011. In vitro assay of bacterial adhesion onto mammalian epithelial cells. J. Vis. Exp. (51):2783.
44. Bunthof, C. J., and T. Abee. 2002. Development of a flow cytometric method to analyze subpopulations of bacteria in probiotic products and dairy starters. Appl. Environ. Microbiol. 68: 2934-2942.
45. Yuan, L., A. Geyer, and L. J. Saif. 2001. Short-term immunoglobulin A B-cell memory resides in intestinal lymphoid tissues but not in bone marrow of gnotobiotic pigs inoculated with Wa human rotavirus. Immunology 103: 188-198.
46. Iosef, C., T. Van Nguyen, K.-i. Jeong, K. Bengtsson, B. Morein, Y. Kim, K.-O. Chang, M. S. Azevedo, L. Yuan, P. Nielsen, and L. J. Saif. 2002. Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes. Vaccine 20: 1741-1753.
47. Trask, S. D., S. M. McDonald, and J. T. Patton. 2012. Structural insights into the coupling of virion assembly and rotavirus replication. Nat. Rev. Microbiol. 10: 165-177.
48. Robinson, C. M., P. R. Jesudhasan, and J. K. Pfeiffer. 2014. Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe 15: 36-46.
49. Ludert, J. E., N. Feng, J. H. Yu, R. L. Broome, Y. Hoshino, and H. B. Greenberg. 1996. Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J. Virol. 70: 487-493.
50. Zhang, B., B. Chassaing, Z. Shi, R. Uchiyama, Z. Zhang, T. L. Denning, S. E. Crawford, A. J. Pruijssers, J. A. Iskarpatyoti, M. K. Estes, et al. 2014. Viral infection: prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18. Science 346: 861-865.
51. Grabig, A., D. Paclik, C. Guzy, A. Dankof, D. C. Baumgart, J. Erckenbrecht, B. Raupach, U. Sonnenborn, J. Eckert, R. R. Schumann, et al. 2006. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via Toll-like receptor 2- and Toll-like receptor 4-dependent pathways. Infect. Immun. 74: 4075-4082.
52. Henker, J., M. Laass, B. M. Blokhin, Y. K. Bolbot, V. G. Maydannik, M. Elze, C. Wolff, and J. Schulze. 2007. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur. J. Pediatr. 166: 311-318.
53. Henker, J., M. W. Laass, B. M. Blokhin, V. G. Maydannik, Y. K. Bolbot, M. Elze, C. Wolff, A. Schreiner, and J. Schulze. 2008. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Pediatr. Infect. Dis. J. 27: 494-499.
54. Butler, J. E., P. Weber, M. Sinkora, D. Baker, A. Schoenherr, B. Mayer, and D. Francis. 2002. Antibody repertoire development in fetal and neonatal piglets. VIII. Colonization is required for newborn piglets to make serum antibodies to T-dependent and type 2 T-independent antigens. J. Immunol. 169: 6822-6830.
55. Haverson, K., Z. Rehakova, J. Sinkora, L. Sver, and M. Bailey. 2007. Immune development in jejunal mucosa after colonization with selected commensal gut bacteria: A study in germ-free pigs. Vet. Immunol. Immunopathol. 119: 243-253.
56. Wechsler-Reya, R. J., and J. G. Monroe. 1996. Lipopolysaccharide prevents apoptosis and induces responsiveness to antigen receptor cross-linking in immature B cells. Immunology 89: 356-362.
57. Hayashi, E. A., S. Akira, and A. Nobrega. 2005. Role of TLR in B cell development: signaling through TLR4 promotes B cell maturation and is inhibited by TLR2. J. Immunol. 174: 6639-6647.
58. Pone, E. J., Z. Lou, T. Lam, M. L. Greenberg, R. Wang, Z. Xu, and P. Casali. 2015. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses. Autoimmunity 48: 1-12.
59. Burdin, N., C. Van Kooten, L. Galibert, J. S. Abrams, J.Wijdenes, J. Banchereau, and F. Rousset. 1995. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J. Immunol. 154: 2533-2544.
60. Rousset, F., E. Garcia, T. Defrance, C. Péronne, N. Vezzio, D. H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89: 1890-1893.
61. Ramsay, A. J., A. J. Husband, I. A. Ramshaw, S. Bao, K. I. Matthaei, G. Koehler, and M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264: 561-563.
62. Karlsson, H., P. Larsson, A. E. Wold, and A. Rudin. 2004. Pattern of cytokine responses to Gram-positive and Gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendritic cells. Infect. Immun. 72: 2671-2678.
63. Hessle, C., B. Andersson, and A. E. Wold. 2000. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while Gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun. 68: 3581-3586.
64. Azevedo, M. S., W. Zhang, K. Wen, A. M. Gonzalez, L. J. Saif, A. E. Yousef, and L. Yuan. 2012. Lactobacillus acidophilus and Lactobacillus reuteri modulate cytokine responses in gnotobiotic pigs infected with human rotavirus. Benef. Microbes 3: 33-42.
65. Zhang, H., H. Wang, M. Shepherd, K. Wen, G. Li, X. Yang, J. Kocher, E. Giri-Rachman, A. Dickerman, R. Settlage, and L. Yuan. 2014. Probiotics and virulent human rotavirus modulate the transplanted human gut microbiota in gnotobiotic pigs. Gut Pathog. 6: 39.
66. Wen, K., C. Tin, H. Wang, X. Yang, G. Li, E. Giri-Rachman, J. Kocher, T. Bui, S. Clark-Deener, and L. Yuan. 2014. Probiotic Lactobacillus rhamnosus GG enhanced Th1 cellular immunity but did not affect antibody responses in a human gut microbiota transplanted neonatal gnotobiotic pig model. PLoS One 9: e94504.
67. Eloe-Fadrosh, E. A., A. Brady, J. Crabtree, E. F. Drabek, B. Ma, A. Mahurkar, J. Ravel, M. Haverkamp, A. M. Fiorino, C. Botelho, et al. 2015. Functional dynamics of the gut microbiome in elderly people during probiotic consumption. MBio 6: 6.
68. Denou, E., E. Rezzonico, J. M. Panoff, F. Arigoni, and H. Brussow. 2009. A Mesocosm of Lactobacillus johnsonii, Bifidobacterium longum, and Escherichia coli in the mouse gut. DNA Cell Biol. 28: 413-422.
69. Patzer, S. I., M. R. Baquero, D. Bravo, F. Moreno, and K. Hantke. 2003. The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology 149: 2557-2570.